Analyst Report: BA

1. EXECUTIVE SUMMARY

Boeing fell 10.69% to $168.18 on Tuesday October 27, 2026, after its third-quarter report showed a wider loss than expected and management said it will miss its 2026 737 delivery target. The Reuters report, carried by BusinessDay, put the adjusted loss at 34c per share against an LSEG consensus of 21c. Free-cash-flow targets of roughly $2bn for 2026 and about $3bn for 2027 came in below Wall Street's expectations, and Jefferies called them "disappointing" (Stocktwits). Volume reached 47,078,000 shares, 6.71 times the 50-session average, and the close set a new 52-week low. Sources attribute the drop to company-specific production and cash-flow issues. The record $745bn backlog and a 44.9 forward P/E leave the shares dependent on the 737 ramp and on cash conversion in 2027.

2. THE CATALYST

Boeing released its third-quarter results before the NYSE open on October 27 (ad-hoc-news), and the whole session's decline followed that release. The stock opened at $183.50, below the prior close of $188.31, and sold off to a low of $167.41.

The facts panel carries an EPS estimate of 0.01 for the quarter. Other sources differ on consensus: Stocktwits cites Fiscal.ai at a 25c loss and AlphaStreet matches LSEG at 21c. Every figure in the brief points to a miss.

Two drivers stand out:

• 737 production and deliveries. The CEO said 2026 737 production and delivery targets will be missed (Reuters via BusinessDay), and CFO Jay Malave said Boeing will miss its target of 500 deliveries this year (Quartz). Boeing targets 52 jets a month in the second half of 2027, with wing output the constraint (Quartz). The CEO said demonstrating performance at the 47 a month rate is taking longer than expected (Private Banker).
• Free cash flow. Boeing now targets roughly $2bn in 2026, about $3bn in 2027, about $6bn in 2028 and $10bn in 2029 (Stocktwits). Jefferies noted that each year's goal had slipped by about a year, and put 2027 consensus near $5.5bn (Reuters via BusinessDay). The CFO expects the 777X to be a significant use of cash in 2027 (Stocktwits).

Reuters reported it as the stock's worst day since April 3, 2025. A Yahoo headline cites a longer span, and the brief advises using the Reuters figure.

3. COMPANY PROFILE

Boeing is an industrials company in aerospace and defense. It operates three segments: Commercial Airplanes; Defense, Space & Security; and Global Services. Its main commercial competitor is Airbus, and defense peers in the panel include Lockheed Martin, Northrop Grumman, General Dynamics and RTX. Market capitalisation is $132.83bn.

Recent results from the Boeing release and press coverage:

• Defense, Space & Security revenue was $7.9bn on higher volume, and the U.S. Navy selected Boeing for the F/A-XX next-generation fighter. That award is outside backlog until source selection and evaluation finish.
• Deliveries were 161 in the quarter, including 124 737s and 22 787s (Private Banker). 787 deliveries are guided to the low end of the 90-100 range for 2026, with output stable at eight a month.
• Total backlog reached a record $745bn.
• Cash and marketable securities were $20.7bn, up from $20.0bn at the start of the quarter, and $10.0bn of credit facilities remain undrawn.
• The 737-7 received amended type certification from the FAA, and the release says the 737-10 achieved it in October. Stocktwits describes the 737-10 timing differently, so the exact date is unsettled.

4. DEEP DIVE ANALYSIS

Do fundamentals justify the move? The earnings miss was 13c per share against LSEG consensus, and the cash-flow path moved out by about a year according to Jefferies. For a stock on a forward P/E of 44.9, valuation rests on a recovery in earnings and cash, so a delay to that recovery carries a direct price consequence. A 10.69% fall for a one-year slip in cash generation is large but consistent with the volume of 6.71 times average.

Peers. Over the same period GE rose 3.20%, while RTX fell 1.46%, LMT 1.92%, HWM 1.22%, NOC 2.51% and GD 0.60%. The S&P 500 gained 0.60%. Sources treat the decline as specific to Boeing, and the brief found no sector news matching the timing. The mild declines at defense peers have no explanation in the brief.

Comparable episodes. On January 27, 2016, Boeing guided to fewer deliveries and below-consensus earnings, and shares fell as much as 10% intraday (Reuters via Business Standard). A 2021 787 delivery halt pushed shares down about 4% over a week (Benzinga). The current session is larger than both.

Analyst context. Targets were cut ahead of the print: TD Cowen to $240 from $250 (October 9), Bernstein to $278 from $298 (October 12), RBC to $235 from $265 (October 15) and Morgan Stanley to $225 from $250 (Benzinga dates it October 19, while MarketBeat dates it October 16). Barclays initiated at Overweight with a $300 target on October 9. The brief found no target changes dated October 27 or 28. Consensus targets of about $266.96 (MarketBeat) and $272.44 (TIKR) sit far above the $168.18 close.

Bull case. Gabelli's analyst said the long-term outlook remains good because jetliner demand is high and Airbus is the only major competitor (Reuters via BusinessDay). The record backlog, undrawn credit lines, 737 certifications and the F/A-XX selection add support.

Bear case. The wing constraint and the slower demonstration of the 47 a month rate push the 52 a month target to late 2027. The 777X draws cash in 2027. Commercial Airplanes lost money at a -6.5% margin. Free cash flow of about $3bn in 2027 sits well under the roughly $5.5bn consensus Jefferies cited.

5. TECHNICAL SNAPSHOT

The close of $168.18 sits just above the 52-week low of $167.41, which was set in the same session, and is the lowest close in the ten-day table. The price is below the 50-day average of $199.11 and the 200-day average of $218.07, and it is 33.88% below the 52-week high of $254.35 from January 27. Year to date the shares are down 26.16%. Volume of 47,078,000 against a 50-session average of 7,020,950 shows heavy institutional repositioning. With the latest close the lowest in the table, no nearby support level exists in the recent closes, and the intraday low of $167.41 is the reference point. The nearest resistance is the $187.55 to $192.28 cluster of closes from before the report.

6. RISK FACTORS

• Further slippage in 737 rates or in the wing supply chain would extend the cash-flow delay.
• The 777X is a significant cash use in 2027, and the first 777-9 delivery is targeted for 2027.
• The 2027 free-cash-flow target of about $3bn sits below consensus, so estimates still need to reset, and target cuts after the print are possible.
• The F/A-XX award adds no backlog until the evaluation review completes.
• The brief found no date for the next earnings report, because the panel's October 27 date refers to the report just released.
• A TradingKey item mentions a $700m legal settlement, which no other source confirms.
• Market coverage on the day pointed to a pending October Fed decision, a macro event with its own effect on the broader market.

7. ACTIONABLE OUTLOOK

Short term (1-2 weeks). The shares trade at a 52-week low after a session at 6.71 times normal volume. Analyst target revisions after the print and any move below the $167.41 low would decide direction, and a recovery toward the $187.55 to $192.28 pre-report closes would need a catalyst the brief does not identify.

Medium term (1-3 months). Delivery data and updates on wing output and the 47 a month rate will drive the stock. Evidence that 737 output is stabilising at 47 a month would support the 2027 cash-flow path, while another delay would lengthen the recovery timeline.

Long term. The thesis of a duopoly with a record $745bn backlog stands, according to the Gabelli view. The timing of cash generation has moved out by about a year per Jefferies, and the 2029 target of $10bn is the figure investors will test against delivery rates. This is analysis only and not personal financial advice.